JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants

JC polyomavirus (JCV) carriers with a compromised immune system, such as in HIV, or subjects on immune-modulating therapies, such as anti VLA-4 therapy may develop progressive multifocal leukoencephalopathy (PML) which is a lytic infection of oligodendrocytes in the brain. Serum antibodies to JCV ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundqvist, Emilie, Buck, Dorothea, Warnke, Clemens, Albrecht, Eva, Gieger, Christian, Khademi, Mohsen, Lima Bomfim, Izaura, Fogdell-Hahn, Anna, Link, Jenny, Alfredsson, Lars, Søndergaard, Helle Bach, Hillert, Jan, Oturai, Annette B., Hemme, Bernhard, Kockum, Ingrid, Olsson, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999271/
https://www.ncbi.nlm.nih.gov/pubmed/24763718
http://dx.doi.org/10.1371/journal.ppat.1004084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999271/
https://www.ncbi.nlm.nih.gov/pubmed/24763718
http://dx.doi.org/10.1371/journal.ppat.1004084

Ejemplares similares